Disease / condition
Type 2 Diabetes Mellitus clinical trials
Free access to 1,536 studies10+ countriesUpdated daily98 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
1,536
Total trials
10+
Countries
10+
Sponsors
98
Recruiting
By phase
N/A598
Phase 3293
Phase 1197
Phase 4195
Phase 2140
By status
Completed1,120
Unknown126
Recruiting98
Not yet recruit...80
Terminated63
Top countries
United States of America255
China149
Japan145
South Korea78
Canada40
Top sponsors
AstraZeneca108
Merck Sharp & Dohm...100
Sanofi76
Eli Lilly and Comp...41
Takeda32
Recent trials
Latest clinical trials for Type 2 Diabetes Mellitus
Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects
Shandong Suncadia Medicine Co.... · China
NCT06422039Not yet recr...
- Phase
- Phase 1
A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Diet and Exercise
HighTide Biopharma Pty Ltd · China
NCT06411275Completed
- Phase
- Phase 2
Research on Changes in Intestinal Barrier Function and Gut Microbiome in Patients With Type 2 Diabetes After Duodenal Mucosal Resurfacing (DMR)
Wang Siqi
NCT06385704Not yet recr...
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
Eli Lilly and Company · United States of America
NCT06362265Not yet recr...
- Phase
- Phase 1
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
HighTide Biopharma Pty Ltd · China
NCT06353347Recruiting
- Phase
- Phase 3
Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
Chengdu Brilliant Pharmaceutic...
NCT06339086Not yet recr...
- Phase
- Phase 3
Protocol for Alpha MSH Infusion Study in Patients With Type 2 Diabetes
Dasman Diabetes Institute · Kuwait
NCT06293664Recruiting
A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of BR3005 and Co-administration of BR3005-1 and BR3005-2 Under Fasting Conditions in Healthy Adult Volunteers
Boryung Pharmaceutical Co., Lt... · South Korea
NCT06289920Recruiting
- Phase
- Phase 1
BFR Walking for Insulin and Aerobic Improvement in Type 2 Diabetes
Arab American University (Pale... · Palestinian
NCT06290947Completed
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Eccogene · United States of America
NCT06293742Recruiting
- Phase
- Phase 1
ECC5004 RBA FE Study in Healthy Participants
Eccogene · United States of America
NCT06268145Recruiting
- Phase
- Phase 1
Phase 3 Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus
CSPC Baike (Shandong) Biopharm...
NCT06258148Not yet recr...
- Phase
- Phase 3
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients
Beijing Dongfang Biotech Co., ... · China
NCT06254014Not yet recr...
- Phase
- Phase 3
Phase 3 Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus
CSPC Baike (Shandong) Biopharm... · China
NCT06235086Not yet recr...
- Phase
- Phase 3
Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Type 2 Diabetes Mellitus.
National Taiwan University Hos... · Taiwan
NCT06212778Recruiting
Assessment of Gastric Emptying by SHR20004 in Healthy Subjects
Jiangsu HengRui Medicine Co., ...
NCT06137469Not yet recr...
- Phase
- Phase 1
Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients
Jeil Pharmaceutical Co., Ltd. · South Korea
NCT06144788Not yet recr...
- Phase
- Phase 2
A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
Novo Nordisk A/S · Argentina,Australia,Brazil,Bulgaria,Canada,China,Colombia,Croatia,Czech,Denmark,Finland,Germany,Gree
NCT06065540Recruiting
- Phase
- Phase 3
A Study to Evaluate the DDI of HSK7653 With Metformin
Haisco Pharmaceutical Group Co... · China
NCT06084156Completed
- Phase
- Phase 1
Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM
Haisco Pharmaceutical Group Co... · China
NCT06059326Completed
- Phase
- Phase 2
About this profile
Access comprehensive clinical trial information for Type 2 Diabetes Mellitus through Pure Global AI's free database. This collection includes 1,536 clinical trials across multiple phases including N/A, Phase 3, Phase 1. Currently, 98 trials are actively recruiting participants.
Research for Type 2 Diabetes Mellitus is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include AstraZeneca and Merck Sharp & Dohme LLC. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,536 clinical trials studying Type 2 Diabetes Mellitus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Merck Sharp & Dohme LLC, Sanofi, among others.